LYPD3 and acute myeloid leukemia: In addition, since there is no evidence that LYPD3 plays a role in proliferative activity or resistance to apoptosis and the two above-mentioned characteristics are thought to be associated with AML pathogenesis according to the above universally recognized views, the most likely explanation may be that LYPD3 acts as a coactivator.